SALT Holding Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Hold
256,134
6.51% 7
2026
Q1
$9.41M Buy
+256,134
New +$12.1M 5.69% 6
2025
Q3
Sell
-24,684
Closed -$1.7M 18
2025
Q2
$1.7M Sell
24,684
-15,300
-38% -$1.04M 2.61% 4
2025
Q1
$2.78M Buy
39,984
+10,013
+33% +$827K 2.57% 6
2024
Q4
$2.58M Buy
+29,971
New +$3.24M 3.16% 4

Other funds holding NVO

SALT Holding Corp's NVO Position: Q2 2026 in Review

SALT Holding Corp held its Novo Nordisk (NVO) position steady in Q2 2026 at 256,134 shares worth $12.3M. The position accounts for 6.51% of the portfolio, ranked #7.

SALT Holding Corp first reported a position in NVO in Q4 2024 and has held it in 5 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SALT Holding Corp held 256,134 shares of Novo Nordisk worth $12.3M as of Q2 2026.
  • SALT Holding Corp left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 6.51% of SALT Holding Corp's portfolio in Q2 2026, its #7 holding.
  • SALT Holding Corp first reported a position in Novo Nordisk in Q4 2024 and has held it in 5 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SALT Holding Corp's 13F filing for Q2 2026, filed 14 Aug 2026.